Exact Sciences (EXAS) Gains from Sales and Divestitures (2016 - 2019)
Exact Sciences (EXAS) has disclosed Gains from Sales and Divestitures for 10 consecutive years, with $3.5 million as the latest value for Q2 2019.
- Quarterly Gains from Sales and Divestitures rose 271.43% to $3.5 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Jun 2019, up 271.43% year-over-year, with the annual reading at $1.3 million for FY2018, 12.85% up from the prior year.
- Gains from Sales and Divestitures for Q2 2019 was $3.5 million at Exact Sciences, up from $3.4 million in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $3.5 million in Q2 2019, with the low at $237061.0 in Q1 2015.
- Average Gains from Sales and Divestitures over 5 years is $1.1 million, with a median of $817710.0 recorded in 2016.
- The sharpest move saw Gains from Sales and Divestitures rose 11.84% in 2018, then soared 286.5% in 2019.
- Over 5 years, Gains from Sales and Divestitures stood at $578033.0 in 2015, then surged by 37.74% to $796168.0 in 2016, then skyrocketed by 42.21% to $1.1 million in 2017, then increased by 12.85% to $1.3 million in 2018, then skyrocketed by 174.4% to $3.5 million in 2019.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $3.5 million, $3.4 million, and $1.3 million for Q2 2019, Q1 2019, and Q4 2018 respectively.